[#item_full_content] A new federal watchdog report is calling on agencies to improve their policies that govern the drug scheduling process—including how they evaluate substances and develop recommendations. The new U.S. Government Accountability Office (GAO) report published on Wednesday comes as the federal government continues to consider whether to comprehensively reschedule marijuana under the Controlled Substances Act
Read More